OMI's image-guided workstation cleared by FDA:
This article was originally published in Clinica
OMI (US) has received 510(k) clearance from the US FDA to market its Mayfield/Acciss image-guided stereotactic workstation for brain surgery in the US. The system uses a directional operational arm to identify the border of abnormalities in the brain, such as tumours. The Cincinnati, Ohio-based company says the workstation could also be used for orthopaedic and spinal surgery in the future.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.